01—Abstract
Summary
Summary of the 8-K filed June 24, 2024. Cited figures are marked; the original filing is the authoritative source.
Bunge Global SA (NYSE: BG) disclosed on June 20, 2024 (reported in an 8-K filed June 24, 2024) that its wholly owned subsidiary Bunge Brasil Holdings B.V. signed a definitive share purchase agreement on June 19, 2024 to sell its 50% stake in BP Bunge Bioenergia, the sugar cane and ethanol joint venture with bp, to bp for an approximate net amount of $800 milliona, subject to closing timing and customary adjustments.
The joint venture, formed in 2019, combines 11 mills across Brazil's Southeast, North and Midwest regions. Upon closing, expected in the fourth quarter of 2024, bp will own 100%b of the business. For investors, the transaction is a clear exit from a non-core asset.
CEO Greg Heckman said the business is not core to Bunge's long-term strategy and that the sale will let the company focus investment on core businesses while further strengthening the balance sheet. The $800 millionc in proceeds is described as the second and final monetization event of Bunge's ownership, indicating the company is fully exiting the venture. J.P.
Morgan is acting as exclusive financial advisor. The key risks are execution-related: completion depends on customary closing conditions, including required regulatory approvals in Brazil, and the proceeds could shift with timing and closing adjustments. The filing does not disclose the accounting gain or loss, the book value of the stake, or how the proceeds will be deployed, so investors should look to subsequent filings for those details.
02—Key points
Key Highlights
- Bunge agreed to sell its 50% stake in BP Bunge Bioenergia to joint venture partner bp for approximately $800 million in net proceeds.
- The sale is the second and final monetization of Bunge's ownership in the Brazilian sugar and ethanol venture, fully exiting the business.
- Closing is expected in Q4 2024 and is subject to customary conditions, including regulatory approvals.
- Management describes the business as non-core to long-term strategy, with proceeds intended to fund core businesses and strengthen the balance sheet.
- The joint venture, formed in 2019, operates 11 mills across Southeast, North and Midwest Brazil.
- J.P. Morgan is exclusive financial advisor; Tauil & Chequer Advogados with Mayer Brown is legal counsel.
- The filing does not disclose the gain or loss on sale or the stake's carrying value, so the earnings impact is unquantified.
03—Questions
Frequently Asked Questions
How much will Bunge receive from the sale?
Bunge expects approximately $800 million in net proceeds, depending on the timing of closing and customary closing adjustments.
Who is buying the stake and what is being sold?
bp, Bunge's joint venture partner, is buying Bunge's 50% ownership share in BP Bunge Bioenergia, which grows sugar cane and produces sugar and sugar ethanol and power cogeneration. Upon closing, bp will own 100% of the business.
When is the transaction expected to close?
Bunge expects the transaction to close in the fourth quarter of 2024, subject to customary conditions including required regulatory approvals.
Why is Bunge selling this business?
Management says the business is not core to Bunge's long-term strategy. The sale is intended to let Bunge focus investment on its core businesses and further strengthen its balance sheet.
Does this sale affect Bunge's earnings?
The filing does not disclose the expected accounting gain or loss or the carrying value of the stake, so the earnings impact cannot be determined from this document. Investors should review subsequent filings for this information.
04—Continue